BEIJING - China is aiming to drive its biological industry into high-speed growth in the next three years, according to an online statement issued by the National Development and Reform Commission (NDRC), China's top economic planner, on Wednesday.
The central government has set a goal of keeping the total output of its biological industry up at least 20 percent each year through 2015, the statement said, citing a guideline on the development of the sector recently issued by the State Council, or China's Cabinet.
The statement quoted an unnamed official as saying that the government also vows to significantly increase the added value that bio-industry creates, making its proportion in the country's gross domestic product double by 2015 from its 2010 level.
Bio-industrial development is very important for the health of the population, grain security, energy conservation and emission reduction, the official said.
The guideline also stipulates the major fields of bio-industry to include its applications in medicine, medical engineering, agriculture, manufacturing, energy, environmental protection and services, the last category of which is newly introduced in the guideline.
Bio-industry is one of the seven strategic new industries China aims to cultivate according to its 12th Five-Year Plan for the 2011-2015 period.
The State Council has previously issued similar guidelines on four other strategic new industries, including the energy conservation and environmental protection sector, high-end equipment manufacturing, the new energy sector and energy-efficient and new-energy automobile manufacture.
Zeng Guang, chief epidemiologist at the Chinese Center for Disease Control and Prevention, told the Global Times that it was still not certain that shutting down poultry businesses would be effective.
"There is still no solid research data showing that the ban of the live poultry trade has slowed the spread of the virus, though it might to some extent help contain cross-infection between poultry in some infected areas," Zeng said.
Zeng added that studies into the prevention of H7N9 are still in the very early stages.
The national commission stated on Wednesday that H7N9 was mainly spread through inhalation, while pointing out that people who are involved in the live poultry trade or slaughter have a high risk of becoming infected.
"Banning the trade and culling birds is only an expedient. Research into vaccines and effective medication are critical," Zeng said.
Why buy milk when you can get the cow. That also answer for Capcod3 (Does China respect US patent law? Post) and Map's concern the other day. Why China wants to do that when BioCryst market cap is so low right now? Mdaddy, do you wants $25 per share? That is not the problem with China right now. Do you still remember my post with 5 million doses at $100 per dose? That is $500 million with one order when they can buy BioCryst for one billion dollars. JMHO.